We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




The COVID-19 Coronavirus Remains Viable for Hours or Days on Solid Surfaces

By LabMedica International staff writers
Posted on 30 Mar 2020
A recently published paper sheds light on how coronavirus spreads through the air and how long it remains viable on various solid surfaces.

A novel coronavirus of zoonotic origin, SARS-CoV-2 (2019-nCoV) was first identified in patients with acute respiratory disease (COVID-19). This virus is genetically similar to SARS coronavirus and bat SARS-like coronaviruses. The outbreak was initially detected in Wuhan, a major city of China, but has subsequently exploded into a pandemic, which is raging in most of the countries of the world. At this time more than 425,000 cases of the disease have been confirmed with thousands of fatalities. Signs of infection are highly non-specific and these include respiratory symptoms, fever, cough, dyspnea, and viral pneumonia. The elderly and those with chronic diseases seem to suffer a more severe disease than does the younger, healthier population.

Many questions remain unanswered regarding how coronavirus spreads. To answer some of them, investigators at the University of California, Los Angeles (USA), the [U.S.] National Institute of Allergy and Infectious Diseases (Bethesda, MD, USA), the [U.S.] Centers for Disease Control and Prevention (Atlanta, GA, USA), and Princeton University (Princeton, NJ, USA) analyzed the aerosol and surface stability of SARS-CoV-2 and compared it with SARS-CoV-1, the most closely related human coronavirus.

For the study, aerosols similar to those observed in samples obtained from the upper and lower respiratory tract in humans, containing SARS-CoV-2 or SARS-CoV-1 were generated with the use of a three-jet Collison nebulizer. In addition, the viability of the viruses was determined in four environmental conditions (plastic, stainless steel, copper, and cardboard).

Results revealed that SARS-CoV-2 remained viable in aerosols throughout the duration of the three hour experiment, but with a small reduction in infectious titer. This reduction was similar to that observed with SARS-CoV-1.

SARS-CoV-2 was more stable on plastic and stainless steel than on copper and cardboard, and viable virus was detected up to 72 hours after application to these surfaces, although the virus titer was greatly reduced. Significant reduction in virus titers were noted after 72 hours on plastic, after 48 hours on stainless steel, 24 hours on cardboard, and only four hours on copper. The stability kinetics of SARS-CoV-1 were similar. This suggests that differences in the epidemiologic characteristics of these viruses probably arise from other factors, including high viral loads in the upper respiratory tract and the potential for persons infected with SARS-CoV-2 to shed and transmit the virus while asymptomatic.

While the results indicated that viable viruses could be detected for hours or days on some surfaces, it was not shown whether these viruses were still capable of causing the disease.

Contributing author Dr. James Lloyd-Smith, professor of ecology and evolutionary biology at the University of California, Los Angeles, said, "This virus is quite transmissible through relatively casual contact, making this pathogen very hard to contain. If you are touching items that someone else has recently handled, be aware they could be contaminated and wash your hands. The biology and epidemiology of the virus make infection extremely difficult to detect in its early stages because the majority of cases show no symptoms for five days or longer after exposure. Many people will not have developed symptoms yet."

The report appeared in the March 17, 2020, online edition of the journal New England Journal of Medicine.

Related Links:
University of California, Los Angeles
[U.S.] National Institute of Allergy and Infectious Diseases
Centers for Disease Control and Prevention
Princeton University



Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Fecal DNA Extraction Kit
QIAamp PowerFecal Pro DNA Kit
New
Centromere B Assay
Centromere B Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The experimental blood test accurately indicates severity and predicts potential recovery from spinal cord injury (Photo courtesy of 123RF)

Blood Test Identifies Multiple Biomarkers for Rapid Diagnosis of Spinal Cord Injury

The National Institutes of Health estimates that 18,000 individuals in the United States sustain spinal cord injuries (SCIs) annually, resulting in a staggering financial burden of over USD 9.... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Industry

view channel
Image: Tumor-associated macrophages visualized using the Multiomic LS Assay (Photo courtesy of ACD)

Leica Biosystems and Bio-Techne Expand Spatial Multiomic Collaboration

Bio-Techne Corporation (Minneapolis, MN, USA) has expanded the longstanding partnership between its spatial biology brand, Advanced Cell Diagnostics (ACD, Newark, CA, USA), and Leica Biosystems (Nussloch,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.